<DOC>
	<DOCNO>NCT00252915</DOCNO>
	<brief_summary>There basic science evidence GM-CSF reconstruct cellular immunity septic patient . In prospective , randomised double-blind , placebo-controlled trial , investigate whether achieved patient severe sepsis septic shock .</brief_summary>
	<brief_title>Reconstruction Monocytic Immunocompetence Granulocyte-macrophage-colony Stimulating Factor ( GM-CSF ) Patients With Severe Sepsis Septic Shock</brief_title>
	<detailed_description>GM-CSF reconstructs cellular immunity septic patient . In prospective , randomised double-blind , placebo-controlled trial , investigate whether achieved patinets severe sepsis septic shock .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Severe sepsis septic shock , Presence infection , 2 SIRS criterion , Acute organ dysfunction , Immunoparalysis , Informed consent Pregnancy , Known allergy study medication component , Moribound patient , Autoimmune disease , HIVinfection , Acute MI pulmonary embolism , Cpr last 72 hour , Patients participate different clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>